Literature DB >> 27613128

Detecting Tumor Metastases: The Road to Therapy Starts Here.

M E Menezes1, S K Das2, I Minn3, L Emdad2, X-Y Wang2, D Sarkar2, M G Pomper3, P B Fisher4.   

Abstract

Metastasis is the complex process by which primary tumor cells migrate and establish secondary tumors in an adjacent or distant location in the body. Early detection of metastatic disease and effective therapeutic options for targeting these detected metastases remain impediments to effectively treating patients with advanced cancers. If metastatic lesions are identified early, patients might maximally benefit from effective early therapeutic interventions. Further, monitoring patients whose primary tumors are effectively treated for potential metastatic disease onset is also highly valuable. Finally, patients with metastatic disease can be monitored for efficacy of specific therapeutic interventions through effective metastatic detection techniques. Thus, being able to detect and visualize metastatic lesions is key and provides potential to greatly improve overall patient outcomes. In order to achieve these objectives, researchers have endeavored to mechanistically define the steps involved in the metastatic process as well as ways to effectively detect metastatic progression. We presently overview various preclinical and clinical in vitro and in vivo assays developed to more efficiently detect tumor metastases, which provides the foundation for developing more effective therapies for this invariably fatal component of the cancerous process.
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Detection techniques; In vitro models; In vivo models; Metastasis; Theranostics; Therapy

Mesh:

Substances:

Year:  2016        PMID: 27613128      PMCID: PMC5029857          DOI: 10.1016/bs.acr.2016.07.001

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


  244 in total

1.  mda-9/Syntenin: a positive regulator of melanoma metastasis.

Authors:  Habib Boukerche; Zao-Zhong Su; Luni Emdad; Patrick Baril; Brigitte Balme; Luc Thomas; Aaron Randolph; Kristoffer Valerie; Devanand Sarkar; Paul B Fisher
Journal:  Cancer Res       Date:  2005-12-01       Impact factor: 12.701

2.  Prostate-specific antigen screening in prostate cancer: perspectives on the evidence.

Authors:  Timothy J Wilt; Peter T Scardino; Sigrid V Carlsson; Ethan Basch
Journal:  J Natl Cancer Inst       Date:  2014-03-04       Impact factor: 13.506

3.  ER, HER2, and TOP2A expression in primary tumor, synchronous axillary nodes, and asynchronous metastases in breast cancer.

Authors:  Jeanette Dupont Jensen; Ann Knoop; Marianne Ewertz; Anne-Vibeke Laenkholm
Journal:  Breast Cancer Res Treat       Date:  2011-06-11       Impact factor: 4.872

Review 4.  Nanoparticle-based theranostic agents.

Authors:  Jin Xie; Seulki Lee; Xiaoyuan Chen
Journal:  Adv Drug Deliv Rev       Date:  2010-08-04       Impact factor: 15.470

Review 5.  Circulating tumour cells in cancer patients: challenges and perspectives.

Authors:  Klaus Pantel; Catherine Alix-Panabières
Journal:  Trends Mol Med       Date:  2010-07-29       Impact factor: 11.951

6.  Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma.

Authors:  Andrew J Aguirre; Nabeel Bardeesy; Manisha Sinha; Lyle Lopez; David A Tuveson; James Horner; Mark S Redston; Ronald A DePinho
Journal:  Genes Dev       Date:  2003-12-17       Impact factor: 11.361

7.  Whole-body magnetic resonance imaging in the detection of skeletal metastases in patients with prostate cancer.

Authors:  R Venkitaraman; G J R Cook; D P Dearnaley; C C Parker; V Khoo; R Eeles; R A Huddart; A Horwich; S A Sohaib
Journal:  J Med Imaging Radiat Oncol       Date:  2009-06       Impact factor: 1.735

Review 8.  Microenvironmental regulation of metastasis.

Authors:  Johanna A Joyce; Jeffrey W Pollard
Journal:  Nat Rev Cancer       Date:  2008-03-12       Impact factor: 60.716

9.  Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma.

Authors:  Julie C Dutoit; Matthias A Vanderkerken; Koenraad L Verstraete
Journal:  Eur J Radiol       Date:  2013-05-28       Impact factor: 3.528

10.  Cell migration and invasion assays as tools for drug discovery.

Authors:  Keren I Hulkower; Renee L Herber
Journal:  Pharmaceutics       Date:  2011-03-11       Impact factor: 6.321

View more
  8 in total

1.  Single-cell RNA-sequencing identifies anti-cancer immune phenotypes in the early lung metastatic niche during breast cancer.

Authors:  Sophia M Orbach; Michael D Brooks; Yining Zhang; Scott E Campit; Grace G Bushnell; Joseph T Decker; Ryan J Rebernick; Sriram Chandrasekaran; Max S Wicha; Jacqueline S Jeruss; Lonnie D Shea
Journal:  Clin Exp Metastasis       Date:  2022-08-24       Impact factor: 4.510

Review 2.  Ruthenium(ii)-arene complexes as anti-metastatic agents, and related techniques.

Authors:  Chanchal Sonkar; Sayantan Sarkar; Suman Mukhopadhyay
Journal:  RSC Med Chem       Date:  2021-09-15

3.  Adaptive F-Actin Polymerization and Localized ATP Production Drive Basement Membrane Invasion in the Absence of MMPs.

Authors:  Laura C Kelley; Qiuyi Chi; Rodrigo Cáceres; Eric Hastie; Adam J Schindler; Yue Jiang; David Q Matus; Julie Plastino; David R Sherwood
Journal:  Dev Cell       Date:  2019-01-24       Impact factor: 12.270

4.  The GAS6-AXL signaling pathway triggers actin remodeling that drives membrane ruffling, macropinocytosis, and cancer-cell invasion.

Authors:  Daria Zdżalik-Bielecka; Agata Poświata; Kamila Kozik; Kamil Jastrzębski; Kay Oliver Schink; Marta Brewińska-Olchowik; Katarzyna Piwocka; Harald Stenmark; Marta Miączyńska
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-13       Impact factor: 11.205

Review 5.  Carotenoids in Cancer Metastasis-Status Quo and Outlook.

Authors:  Lenka Koklesova; Alena Liskova; Marek Samec; Kevin Zhai; Mariam Abotaleb; Milad Ashrafizadeh; Aranka Brockmueller; Mehdi Shakibaei; Kamil Biringer; Ondrej Bugos; Masoud Najafi; Olga Golubnitschaja; Dietrich Büsselberg; Peter Kubatka
Journal:  Biomolecules       Date:  2020-12-10

6.  Assessment of DAPK1 and CAVIN3 Gene Promoter Methylation in Breast Invasive Ductal Carcinoma and Metastasis.

Authors:  Esmat Ghalkhani; Mohammad Taghi Akbari; Pantea Izadi; Habibollah Mahmoodzadeh; Fatemeh Kamali
Journal:  Cell J       Date:  2021-08-29       Impact factor: 2.479

7.  A Unique Core-Shell Structured, Glycol Chitosan-Based Nanoparticle Achieves Cancer-Selective Gene Delivery with Reduced Off-Target Effects.

Authors:  Bei Cheng; Hye-Hyun Ahn; Hwanhee Nam; Zirui Jiang; Feng J Gao; Il Minn; Martin G Pomper
Journal:  Pharmaceutics       Date:  2022-02-07       Impact factor: 6.525

8.  Sonographic Assessment of the Normal and Abnormal Feline Mammary Glands and Axillary and Inguinal Lymph Nodes.

Authors:  Nayara S Moraes; Naida C Borges
Journal:  Vet Med Int       Date:  2021-07-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.